photographic A pharmaceutical professional reviewing documents at a sleek modern desk EU flag subtly visible in soft focus in the background floortoce-1

Accelerate Your Market Entry into Europe

Expand your pharmaceutical business into Europe with a partner who understands both strategy and execution. From regulatory pathway definition to EU-GMP readiness, importation, and lifecycle management, QbD Group provides the integrated capabilities required to establish and sustain your presence in the European market.

 

Europe offers opportunity. But it demands preparation.

Europe is the world’s second largest pharmaceutical market, representing 500+ million patients across more than 30 interconnected countries. It offers scale, pricing potential, and long-term stability.

 

But entry requires navigating:

  • A complex EU regulatory framework
  • National differences in legislation
  • Strict EU-GMP requirements and QP oversight
  • Multiple registration procedures
  • Operational obligations long before commercialization

 

Without European infrastructure, expansion can quickly become fragmented and resource-heavy.

photographic Photorealistic medium shot of a diverse group of three pharmaceutical consultants  two women and one man  gathered around a glass desk re-1
Accelerate Your Market Entry into Europe - QbD Group-1-1

One Integrated Pathway to European Market Access

At QbD Group, we align regulatory strategy with operational readiness. This reduces risk, shortens timelines, and ensures sustainable entry into the European pharmaceutical market.

We support you from early planning to commercialization and beyond, with one coordinated structure and a single point of accountability.

 

How We Support Your European Expansion

We support pharmaceutical companies across every stage of their European expansion. From early strategic planning and EU-GMP readiness to registration, launch preparation, and ongoing lifecycle management, our services are structured to guide you step by step through a compliant and controlled market entry.

Explore

Strategic Preparation

Pre-Registration & EU-GMP Readiness

Build a strong foundation before entering the European market. We deliver EU market analysis, regulatory road mapping, clinical and product development support, and EU-GMP audits for APIs and finished products — alongside the MAH, Pharmacovigilance, and EU QP structures needed for compliance from day one.


Start your European journey with a strong and fully compliant strategic foundation.

account_balance

Regulatory Approval

Registration & Submission Management

Navigate the European approval process with clarity and control. We define the right registration strategy, prepare your Marketing Authorization dossier in eCTD format, and manage submissions through to approval — ensuring full alignment with EU regulatory requirements at every step.


Reach the European market with a streamlined, expertly managed approval pathway.

local_shipping

Operational Setup

Launch & EU-GMP Importation

Get all critical operations in place before commercialization begins. We establish your EU supply chain, coordinate serialization, and provide GMP-compliant import warehousing and QC testing. Our EU Qualified Persons handle batch certification and release in line with EU-GMP standards.


Launch confidently with integrated, compliant operations fully aligned with EU requirements.

shield

Lifecycle Management

Marketing Authorization & Safety Oversight

Sustain your market access with structured regulatory and safety support. We manage renewals, variations, and full Pharmacovigilance and Medical Information services — keeping your product compliant, safe, and commercially stable across Europe.


Safeguard your authorization and sustain your market presence with expert lifecycle and safety management.

Proven results across Europe

Our clients' success is the best measure of what we do. Across therapeutic areas, geographies, and product types, QbD Group has helped pharmaceutical companies navigate the complexity of European market entry — from first submission to sustained commercialization.

tablets medicine

Supporting Market Access to Essential Medicines in Europe

Enter the European pharma market with expert regulatory guidance from QbD Group, ensuring compliance and patient access to essential medicines.

Why QbD Group?

European expansion requires more than isolated expertise.

It requires integration.

Integrated End-to-End Capabilities

Integrated End-to-End Capabilities

Regulatory, quality, QP, PV, and supply chain services coordinated within one structure. Scalable support from submission to commercialization, backed by EU-based warehousing and import capabilities.

Certified EU-GMP Infrastructure

Certified EU-GMP Infrastructure

GMP-licensed facilities enabling compliant importation, batch certification, and quality oversight under recognized EU standards.

700+ Multidisciplinary Experts

700+ Multidisciplinary Experts

Specialists across regulatory affairs, quality, QC, QP, and PV supporting every stage of your product lifecycle.

Single Point of Accountability

Single Point of Accountability

A dedicated project manager coordinating all workstreams and ensuring structured, consistent progress.

Proven Global Track Record

Proven Global Track Record

4,500+ projects delivered and 1,200+ clients supported across diverse markets and product types.

 

contact-mail

Get in touch

Ready to enter the European market?

Talk to our experts and discover how QbD Group can accelerate your path to market — compliantly and confidently.

Contact_form